MSU
DGX icon

Maple Securities USA’s Quest Diagnostics DGX Stock Holding History

Maple Securities USA’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,248
Closed -$367K – 242
2014
Q2 		$367K Buy
+6,248
New +$366K 0.04% 132
2014
Q1 		– Sell
-23,673
Closed -$1.27M – 213
2013
Q4 		$1.27M Buy
+23,673
New +$1.4M 0.09% 91

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Maple Securities USA's DGX Position: Q3 2014 in Review

Maple Securities USA sold out of Quest Diagnostics (DGX) in Q3 2014, closing a stake of 6,248 shares — an estimated $367K sold.

Maple Securities USA first reported a position in DGX in Q4 2013 and held it in 2 quarters. The position peaked at $1.27M in Q4 2013. 485 funds tracked by Wall St. Rank hold DGX as of Q3 2014.

  • Maple Securities USA reported no remaining Quest Diagnostics position as of Q3 2014 after selling out during the quarter.
  • Maple Securities USA sold 6,248 Quest Diagnostics shares in Q3 2014, an estimated $367K.
  • Maple Securities USA first reported a position in Quest Diagnostics in Q4 2013 and held it in 2 quarters.
  • Maple Securities USA's Quest Diagnostics position peaked at $1.27M in Q4 2013.
  • 485 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2014.

Based on Maple Securities USA's 13F filing for Q3 2014, filed 21 Oct 2014.